HealthTree Logo
search more_vert
close
person Sign In / Create Account

Cutaneous T-cell lymphoma (CTCL) is diagnosed through a combination of physical examinations, blood tests, bone marrow tests, and imaging tests. The process involves identifying the presence of abnormal T-cells in the skin, blood, or other tissues. The diagnosis is often challenging due to the similarity of symptoms with other skin conditions.

Blood Tests:

  • Complete blood count (CBC): A CBC measures the number of different blood cell types, including red blood cells, white blood cells, and platelets. Abnormalities in the CBC may suggest anemia (low red blood cell count), leukocytosis (elevated white blood cell count), or thrombocytopenia (low platelet count), which can occur in CTCL.
  • Peripheral blood smear: A peripheral blood smear is a microscopic examination of a thin layer of blood to assess the shape and appearance of blood cells. It can help identify abnormal or atypical lymphocytes that may be present in the blood of individuals with CTCL.
  • Lymphocyte subset analysis: This test evaluates the distribution of different types of lymphocytes in the blood, including T-cells and B-cells. In CTCL, there is typically an increased number of abnormal T-cells, and this test can help confirm the presence of these cells.
  • Erythrocyte sedimentation rate (ESR): ESR measures the rate at which red blood cells settle in a tube of blood. An elevated ESR can be a nonspecific sign of inflammation, which may occur in individuals with CTCL.
  • Liver and kidney function tests: Blood tests such as liver function tests (aka liver enzymes) and kidney function tests are performed to assess the overall health of these organs. Abnormalities in these tests may occur in some cases of CTCL, particularly when the disease has progressed.
  • Lactate dehydrogenase (LDH): LDH is an enzyme found in cells throughout the body. Elevated LDH levels can be a marker of cell damage or disease activity and may be monitored to assess disease progression or response to treatment.

Bone Marrow Tests:

  • Bone marrow aspiration and biopsy: These tests involve taking a small sample of bone marrow tissue and fluid to look for abnormal cells. They can help determine if the lymphoma has spread to the bone marrow. A bone marrow biopsy can provide information about the architecture of the bone marrow and any infiltration by abnormal lymphocytes. In CTCL, it can help confirm the diagnosis and determine the extent of bone marrow involvement.
  • Immunohistochemistry: Immunohistochemistry is a laboratory technique used to stain and identify specific proteins within the bone marrow tissue. In CTCL, immunohistochemistry can help identify and characterize the atypical T-cells present in the bone marrow.
  • Flow cytometry: This test is used to measure the number and percentage of different types of cells in the blood. It can help identify abnormal T-cells that are characteristic of CTCL.
  • Cytogenetic Analysis: This test looks at the chromosomes of cells in the bone marrow. It can help identify genetic changes that are characteristic of CTCL.
  • T-cell Receptor (TCR) Gene Rearrangement Test: This test looks for changes in the genes of T-cells. It can help confirm a diagnosis of CTCL.

Imaging Tests:

  • Computed Tomography (CT) scan: This test uses X-rays to create detailed images of the inside of the body. It can help identify enlarged lymph nodes or other signs of lymphoma.
  • Positron Emission Tomography (PET) scan: This test uses a small amount of radioactive glucose to identify cancer cells in the body. It can help determine the extent of the lymphoma and whether it has spread to other parts of the body.

A Summary of Diagnosing Cutaneous T-Cell Lymphoma

It's important to note that the diagnosis and classification of CTCL is complex and requires a comprehensive evaluation by a team of specialists. A complete diagnosis requires a physical examination, looking at a bone marrow sample under the microscope, immunophenotyping, and genetic testing. The specific markers and genetic changes found in the bone marrow sample can also help determine a person's prognosis and guide treatment decisions. If you don't currently have an CTCL specialist on your team, it is important that you consult with one. Use HealthTree's CTCL Specialist Directory to locate a specialist near you. 

Want to Learn More About Cutaneous T-Cell Lymphoma?

Keep reading HealthTree for Cutaneous T-Cell Lymphoma's 101 pages!

Cutaneous T-cell lymphoma (CTCL) is diagnosed through a combination of physical examinations, blood tests, bone marrow tests, and imaging tests. The process involves identifying the presence of abnormal T-cells in the skin, blood, or other tissues. The diagnosis is often challenging due to the similarity of symptoms with other skin conditions.

Blood Tests:

  • Complete blood count (CBC): A CBC measures the number of different blood cell types, including red blood cells, white blood cells, and platelets. Abnormalities in the CBC may suggest anemia (low red blood cell count), leukocytosis (elevated white blood cell count), or thrombocytopenia (low platelet count), which can occur in CTCL.
  • Peripheral blood smear: A peripheral blood smear is a microscopic examination of a thin layer of blood to assess the shape and appearance of blood cells. It can help identify abnormal or atypical lymphocytes that may be present in the blood of individuals with CTCL.
  • Lymphocyte subset analysis: This test evaluates the distribution of different types of lymphocytes in the blood, including T-cells and B-cells. In CTCL, there is typically an increased number of abnormal T-cells, and this test can help confirm the presence of these cells.
  • Erythrocyte sedimentation rate (ESR): ESR measures the rate at which red blood cells settle in a tube of blood. An elevated ESR can be a nonspecific sign of inflammation, which may occur in individuals with CTCL.
  • Liver and kidney function tests: Blood tests such as liver function tests (aka liver enzymes) and kidney function tests are performed to assess the overall health of these organs. Abnormalities in these tests may occur in some cases of CTCL, particularly when the disease has progressed.
  • Lactate dehydrogenase (LDH): LDH is an enzyme found in cells throughout the body. Elevated LDH levels can be a marker of cell damage or disease activity and may be monitored to assess disease progression or response to treatment.

Bone Marrow Tests:

  • Bone marrow aspiration and biopsy: These tests involve taking a small sample of bone marrow tissue and fluid to look for abnormal cells. They can help determine if the lymphoma has spread to the bone marrow. A bone marrow biopsy can provide information about the architecture of the bone marrow and any infiltration by abnormal lymphocytes. In CTCL, it can help confirm the diagnosis and determine the extent of bone marrow involvement.
  • Immunohistochemistry: Immunohistochemistry is a laboratory technique used to stain and identify specific proteins within the bone marrow tissue. In CTCL, immunohistochemistry can help identify and characterize the atypical T-cells present in the bone marrow.
  • Flow cytometry: This test is used to measure the number and percentage of different types of cells in the blood. It can help identify abnormal T-cells that are characteristic of CTCL.
  • Cytogenetic Analysis: This test looks at the chromosomes of cells in the bone marrow. It can help identify genetic changes that are characteristic of CTCL.
  • T-cell Receptor (TCR) Gene Rearrangement Test: This test looks for changes in the genes of T-cells. It can help confirm a diagnosis of CTCL.

Imaging Tests:

  • Computed Tomography (CT) scan: This test uses X-rays to create detailed images of the inside of the body. It can help identify enlarged lymph nodes or other signs of lymphoma.
  • Positron Emission Tomography (PET) scan: This test uses a small amount of radioactive glucose to identify cancer cells in the body. It can help determine the extent of the lymphoma and whether it has spread to other parts of the body.

A Summary of Diagnosing Cutaneous T-Cell Lymphoma

It's important to note that the diagnosis and classification of CTCL is complex and requires a comprehensive evaluation by a team of specialists. A complete diagnosis requires a physical examination, looking at a bone marrow sample under the microscope, immunophenotyping, and genetic testing. The specific markers and genetic changes found in the bone marrow sample can also help determine a person's prognosis and guide treatment decisions. If you don't currently have an CTCL specialist on your team, it is important that you consult with one. Use HealthTree's CTCL Specialist Directory to locate a specialist near you. 

Want to Learn More About Cutaneous T-Cell Lymphoma?

Keep reading HealthTree for Cutaneous T-Cell Lymphoma's 101 pages!

Get the latest thought leadership on Cutaneous T-Cell Lymphoma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Cutaneous T-Cell Lymphoma Newsletter" for Cutaneous T-Cell Lymphoma news, life with Cutaneous T-Cell Lymphoma stories, Cutaneous T-Cell Lymphoma clinical trials, Cutaneous T-Cell Lymphoma 101 articles and events with Cutaneous T-Cell Lymphoma experts.